The purpose of this session is to explore the different approaches to evaluating the patient with chronic liver disease and cirrhosis. Chronic liver disease, most commonly due to alcoholism or the hepatitis B or C virus, is very prevalent in the United States. Grey-scale ultrasound of the patient with chronic liver disease is widely used, often with color doppler to survey for cirrhosis, hepatocellular carcinoma, and portal hypertension. This session will also focus on the importance of the advanced techniques of US and MR elastography that can quantify liver fibrosis in the patient with chronic liver disease. Finally there will be a discussion on the role of IV contrast agents in evaluating the chronic liver disease patient with a suspicious lesion. Developed in conjunction with Society of Radiologists in Ultrasound.
Laurence Needleman, MD, FACR - This speaker has nothing to disclose
Richard Barr, MD, Ph.D, FACR, FSRU - This speaker has nothing to disclose
Richard Ehman, MD, FACR - Royalty Income - Resoundant Inc. ; Officer, Director - Resoundant Inc.; Research Grants - National Institutes of Health|Resoundant Inc.; Intellectual Property Rights- Resoundant Inc.
Sharlene Teefey, MD, FACR - This speaker has nothing to disclose
Michelle Robbin, MD,MS, FACR, FSRU,FAIUM - Research Grants - Phillips Healthcare
You must be logged in and own this session in order to post comments.